Yusuf Yilmaz1 , Mujdat Zeybel2 , Gupse Adali3 , Arif Mansur Cosar4 , Elif Sertesen5 , Hale Gokcan6 , Halil Ibrahim Bahcecioglu7 , Mustafa Sahin8 , Cansin Tulunay9 , Ihsan Ergun10 , Ilker Turan11 , Ilkay Sedakat Idilman12 , Cigdem Celikel13 , Hale Kirimlioglu14 , Gülen Akyol15 , Funda Yilmaz16 , Cenk Sokmensuer17 , Hakan Guveli18 , Ulus Salih Akarca11 , Umit Akyuz19 , Volkan Genc20 , Murat Akyildiz21 , Nuray Yazihan21 , Engin Tutar22 , Fehmi Ates23 , Dinc Dincer24 , Yasemin Balaban25 , Murat Kiyici26 , Meral Akdogan27 , Abdullah Sonsuz28 , Ramazan Idilman6 , Members of Fatty Liver Special Interest Group - 2Department of Gastroenterology, Koc University School of Medicine, Istanbul, Türkiye
3Department of Gastroenterology, Health Sciences University, Umraniye Training and Research Hospital, Istanbul, Türkiye
4Department of Gastroenterology, Karadeniz Technical University School of Medicine, Trabzon, Türkiye
5Department of Oncology, Health Sciences University, Abdurrahman Yurtaslan Oncology Research and Training Hospital, Ankara, Türkiye
6Department of Gastroenterology, Ankara University School of Medicine, Ankara, Türkiye
7Department of Gastroenterology, Firat University School of Medicine, Elazig, Türkiye
8Department of Endocrinology, Ankara University School of Medicine, Ankara, Türkiye
9Department of Cardiology, Ankara University School of Medicine, Ankara, Türkiye
10Department of Nefrology, Ufuk University School of Medicine, Ankara, Türkiye
11Department of Gastroenterology, Ege University School of Medicine, Izmir, Türkiye
12Department of Radiology, Hacettepe University School of Medicine, Ankara, Türkiye
13Department of Pathology, Marmara University School of Medicine, Istanbul, Türkiye
14Department of Pathology, Acibadem Mehmet Ali Aydinlar University School of Medicine, Malatya, Türkiye
15Department of Pathology Gazi University School of Medicine, Ankara, Türkiye
16Department of Pathology, Ege University School of Medicine, Izmir, Türkiye
17Department of Pathology, Hacettepe University School of Medicine, Ankara, Türkiye
18Department of Gastroenterology, Bahcesehir University School of Medicine, Istanbul, Türkiye
19Department of Gastroenterology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Türkiye
20Department of General Surgery, Ankara University School of Medicine, Ankara, Türkiye
21Department of Pathophysiology, Ankara University School of Medicine, Ankara, Türkiye
22Department of Pediatric Gastroenterology, Marmara University School of Medicine, Istanbul, Türkiye
23Department of Gastroenterology, Mersin University School of Medicine, Mersin, Türkiye;
24Department of Gastroenterology, Akdeniz University School of Medicine, Antalya, Türkiye
25Department of Gastroenterology, Hacettepe University School of Medicine, Ankara, Türkiye
26Department of Gastroenterology, Uludag University School of Medicine, Bursa, Türkiye
27Department of Gastroenterology, Health Sciences University, Ankara City Hospital, Ankara, Türkiye
28Department of Gastroenterology, Istanbul University Cerrahpasa School of Medicine, Türkiye
29
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a multisystem disease and is sig-nificantly associated with obesity, insulin resistance, type 2 diabetes mellitus, metabolic syndrome, and cardiovascular disease. NAFLD has become the most prevalent chronic liver disease in Western countries, and the proportion of NAFLD-related cirrhosis among patients on liver transplantation waiting lists has increased. In light of the accumulated data about NAFLD, and to provide a common approach with multi-disciplines dealing with the subject, it has become necessary to create new guidance for diagnosing and treating NAFLD. This guidance was prepared following an interdisciplinary study under the leadership of the Turkish Association for the Study of the Liver (TASL), Fatty Liver Special Interest Group. This new TASL Guidance is a practical application guide on NAFLD and was prepared to standardize the clinical approach to diagnosing and treating NAFLD patients. This guidance reflects many advances in the field of NAFLD. The proposals in this guidance are meant to aid decision-making in clinical practice. The guidance is primar-ily intended for gastroenterology, endocrinology, metabolism diseases, cardi-ology, internal medicine, pediatric specialists, and family medicine specialists.
